Cargando…

Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target

Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated. Yet, the activity of YAP-1 in ocular surface squamous neoplasia (OSSN) has not been determined. Here, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Julius, Peter, Siyumbwa, Stepfanie N., Maate, Fred, Moonga, Phyllis, Kang, Guobin, Kaile, Trevor, West, John T., Wood, Charles, Angeletti, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354641/
https://www.ncbi.nlm.nih.gov/pubmed/37476371
http://dx.doi.org/10.3389/fonc.2023.1213426
_version_ 1785074970534084608
author Julius, Peter
Siyumbwa, Stepfanie N.
Maate, Fred
Moonga, Phyllis
Kang, Guobin
Kaile, Trevor
West, John T.
Wood, Charles
Angeletti, Peter C.
author_facet Julius, Peter
Siyumbwa, Stepfanie N.
Maate, Fred
Moonga, Phyllis
Kang, Guobin
Kaile, Trevor
West, John T.
Wood, Charles
Angeletti, Peter C.
author_sort Julius, Peter
collection PubMed
description Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated. Yet, the activity of YAP-1 in ocular surface squamous neoplasia (OSSN) has not been determined. Here, we investigate the relationship between YAP-1 overexpression and OSSN. Using a cross-sectional study design, we recruited 227 OSSN patients from the University Teaching Hospitals in Lusaka, Zambia. Immunohistochemistry was used to assess YAP-1 protein overexpression in tumor tissue relative to surrounding benign squamous epithelium. OSSN patient samples (preinvasive, n = 62, 27% and invasive, n = 165, 73%) were studied. One hundred forty-nine invasive tumors contained adjacent preinvasive tissue, bringing the total number of preinvasive lesions examined to 211 (62 + 149). There was adjacent benign squamous epithelium in 50.2% (114/227) of OSSN samples. Nuclear YAP- 1 was significantly overexpressed in preinvasive (Fisher’s (F): p <.0001, Monte Carlo (MC): p <.0001) and invasive (F: p <.0001, MC: p <.0001) OSSN in comparison to adjacent benign squamous epithelium when analyzed for basal keratinocyte positive count, staining intensity, expression pattern, and Immunostaining intensity-distribution index. YAP-1 expression did not differ between preinvasive and invasive OSSN (p >.05), keratinizing and non- keratinizing cancer (p >.05), or between T1/T2 and T3/T4 stages in invasive tumors (p >.05). However, grade 2 and 3 tumors had significantly stronger nucleus YAP-1 overexpression intensity than grade 1 tumors (F: p = .0078, MC: p = .0489). By immunohistochemistry, we identified significant overexpression (upregulation of YAP-1 protein expression) in preinvasive and invasive OSSN lesions compared to neighboring benign squamous epithelium. YAP-1 expression was significantly higher in poorly and moderately differentiated invasive squamous cancer than in well-differentiated carcinomas. Overexpression of YAP-1 within the margin of preinvasive and invasive OSSN, but not in the neighboring normal epithelium, indicates that it plays a role in the development and progression of OSSN.
format Online
Article
Text
id pubmed-10354641
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103546412023-07-20 Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target Julius, Peter Siyumbwa, Stepfanie N. Maate, Fred Moonga, Phyllis Kang, Guobin Kaile, Trevor West, John T. Wood, Charles Angeletti, Peter C. Front Oncol Oncology Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated. Yet, the activity of YAP-1 in ocular surface squamous neoplasia (OSSN) has not been determined. Here, we investigate the relationship between YAP-1 overexpression and OSSN. Using a cross-sectional study design, we recruited 227 OSSN patients from the University Teaching Hospitals in Lusaka, Zambia. Immunohistochemistry was used to assess YAP-1 protein overexpression in tumor tissue relative to surrounding benign squamous epithelium. OSSN patient samples (preinvasive, n = 62, 27% and invasive, n = 165, 73%) were studied. One hundred forty-nine invasive tumors contained adjacent preinvasive tissue, bringing the total number of preinvasive lesions examined to 211 (62 + 149). There was adjacent benign squamous epithelium in 50.2% (114/227) of OSSN samples. Nuclear YAP- 1 was significantly overexpressed in preinvasive (Fisher’s (F): p <.0001, Monte Carlo (MC): p <.0001) and invasive (F: p <.0001, MC: p <.0001) OSSN in comparison to adjacent benign squamous epithelium when analyzed for basal keratinocyte positive count, staining intensity, expression pattern, and Immunostaining intensity-distribution index. YAP-1 expression did not differ between preinvasive and invasive OSSN (p >.05), keratinizing and non- keratinizing cancer (p >.05), or between T1/T2 and T3/T4 stages in invasive tumors (p >.05). However, grade 2 and 3 tumors had significantly stronger nucleus YAP-1 overexpression intensity than grade 1 tumors (F: p = .0078, MC: p = .0489). By immunohistochemistry, we identified significant overexpression (upregulation of YAP-1 protein expression) in preinvasive and invasive OSSN lesions compared to neighboring benign squamous epithelium. YAP-1 expression was significantly higher in poorly and moderately differentiated invasive squamous cancer than in well-differentiated carcinomas. Overexpression of YAP-1 within the margin of preinvasive and invasive OSSN, but not in the neighboring normal epithelium, indicates that it plays a role in the development and progression of OSSN. Frontiers Media S.A. 2023-07-05 /pmc/articles/PMC10354641/ /pubmed/37476371 http://dx.doi.org/10.3389/fonc.2023.1213426 Text en Copyright © 2023 Julius, Siyumbwa, Maate, Moonga, Kang, Kaile, West, Wood and Angeletti https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Julius, Peter
Siyumbwa, Stepfanie N.
Maate, Fred
Moonga, Phyllis
Kang, Guobin
Kaile, Trevor
West, John T.
Wood, Charles
Angeletti, Peter C.
Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
title Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
title_full Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
title_fullStr Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
title_full_unstemmed Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
title_short Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
title_sort yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354641/
https://www.ncbi.nlm.nih.gov/pubmed/37476371
http://dx.doi.org/10.3389/fonc.2023.1213426
work_keys_str_mv AT juliuspeter yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT siyumbwastepfanien yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT maatefred yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT moongaphyllis yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT kangguobin yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT kailetrevor yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT westjohnt yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT woodcharles yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget
AT angelettipeterc yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget